Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Ionis Pharmaceuticals | IONS - Ebitda
Keuangan
Harga Saham
USD
Aktiva
USD 2.99B
Kas Dan Setara
USD 350.07M
Biaya Penjualan
USD 2.74M
Aset Lancar
USD 2.49B
Kewajiban Lancar
USD 315.64M
UTANG
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
Karyawan
1.07K
Eps Laba Per Saham
USD -0.69
Modal Dan Cadangan
USD 439.74M
Laba Kotor Pada Penjualan
USD 265M
Beban Bunga Utang
USD 18M
Pendapatan Bunga
USD -0.66
Modal Pinjaman
USD 1.91B
Kapitalisasi Pasar
USD 8.18B
Batas Pemasukan
USD -114.65M
Biaya Operasional
USD 370.24M
Laba Operasional
USD -102.29M
Modal Saham Biasa
USD 165.64M
Pe Harga Untuk Laba
396.15
Laba Sebelum Pajak
USD -114M
Pendapatan Penjualan
USD 268M
Beban Penjualan Dan Administrasi
USD 130.08M
Saham
USD 50.83M
Kreditur Perdagangan
USD 47.7M
Debitur Perdagangan
USD 58.85M
Ebitda
Perubahan
Tanggal
Agios Pharmaceuticals
USD -108.66M
11.65M
2026-03
Alnylam Pharmaceuticals
USD 245.34M
59.15M
2026-06
Arrowhead Research
USD -147.68M
40.33M
2026-06
Astellas Pharma
JPY 235.24B
136.32B
2026-06
BioCryst Pharmaceuticals
USD 51.7M
30.14M
2025-09
BioMarin Pharmaceutical
USD 146.05M
170.22M
2026-03
Celltrion
KRW 19.64B
1.85B
2026-03
Cspc Pharmaceutical
CNY 2.19B
21.88M
2024-12
Deva Holding AS
TRY 882.9M
201.7M
2023-09
Divis Laboratories Ltd
INR 12.62B
3.28B
2026-06
Exelixis
USD 255.4M
2.89M
2026-06
Halozyme Therapeutics
USD 328.81M
109.24M
2026-06
Ionis Pharmaceuticals
USD -64.53M
135.49M
2026-03
Kangmei Pharma
CNY -12.72M
30.02M
2026-03
Knight Therapeutics
CAD 24.45M
3.46M
2025-12
Laboratorios Farma
EUR 34.94M
102.95M
2025-06
Malin Corporation
EUR -1.1M
200K
2024-12
Medical Developments International
AUD 1.78M
3.78M
2024-12
Moderna
USD -1.26B
468M
2026-03
Nektar Therapeutics
USD -38.9M
7.09M
2026-03
Neuren Pharmaceuticals
AUD 11.14M
165.56M
2025-12
Neurocrine Biosciences
USD 193.3M
25.1M
2026-03
Novartis
USD 6.48B
1.19B
2026-06
Omeros
USD -47.96M
7.39M
2023-09
OPKO Health
USD -27.82M
103.34M
2026-03
Organigram Holdings
CAD -4.76M
10.02M
2026-03
Pfizer
USD 6.01B
18M
2026-06
Pharma Mar
EUR 700K
2.01M
2026-06
PTC Therapeutics
USD 61.98M
132.97M
2026-03
Qiagen NV
USD 207.66M
59.56M
2026-06
Regeneron Pharmaceuticals
USD 1.66B
695.2M
2026-06
Roche Holding
CHF 13.43B
744M
2026-06
Sarepta Therapeutics
USD 375.48M
627.68M
2026-03
Sartorius
EUR 280.5M
13.2M
2026-06
Sino Biopharmaceutical
CNY 2.59B
1.57B
2024-12
Tilray
USD 8.36M
1.82M
2025-09
Ultragenyx Pharmaceutical
USD -155M
55.57M
2026-03
Vertex Pharmaceuticals
USD 1.33B
130.5M
2026-06
Zealand Pharma A/S
-379M
348.47M
2026-03
Zhangzhou Pientzehuang Pharmaceutical
CNY 882.7M
351.1M
2026-03
×